INTELLIPHARMACEUTICS INTL IN's ticker is IPCI and the CUSIP is 458173101. A total of 24 filers reported holding INTELLIPHARMACEUTICS INTL IN in Q3 2017. The put-call ratio across all filers is 8.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 6 | -62.5% | 0.00% | – |
| Q2 2017 | $0 | – | 16 | 0.0% | 0.00% | – |
| Q1 2017 | $0 | – | 16 | +166.7% | 0.00% | – |
| Q4 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2016 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q4 2015 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | -100.0% | 6 | -98.6% | 0.00% | – |
| Q2 2015 | $1,000 | – | 425 | +5971.4% | 0.00% | – |
| Q1 2015 | $0 | – | 7 | -93.5% | 0.00% | – |
| Q4 2014 | $0 | – | 107 | +1428.6% | 0.00% | – |
| Q3 2014 | $0 | -100.0% | 7 | -99.4% | 0.00% | – |
| Q2 2014 | $4,000 | -73.3% | 1,106 | -68.5% | 0.00% | – |
| Q1 2014 | $15,000 | 0.0% | 3,506 | -12.5% | 0.00% | – |
| Q4 2013 | $15,000 | – | 4,006 | +66666.7% | 0.00% | – |
| Q3 2013 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2013 | $0 | – | 6 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atria Investments, Inc | 75,895 | $159,000 | 0.02% |
| FIRST FOUNDATION ADVISORS | 100,900 | $212,000 | 0.02% |
| Argent Trust Co | 15,121 | $32,000 | 0.01% |
| Acrospire Investment Management LLC | 1,500 | $3,000 | 0.00% |
| Virtu KCG Holdings LLC | 33,485 | $70,000 | 0.00% |
| SIMPLEX TRADING, LLC | 9,846 | $20,000 | 0.00% |
| Advisor Group, Inc. | 11,791 | $25,000 | 0.00% |
| Hudson Bay Capital Management LP | 10,000 | $21,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,038 | $2,000 | 0.00% |